Stem cell decisions
This is an old revision of this page, as edited by Aschlafly (talk | contribs) at 05:07, April 26, 2023. It may differ significantly from current revision.
Stem cell decisions include this growing list:
- United States v. Cal. Stem Cell Treatment Ctr., No. EDCV 18-1005 JGB (KKx), 2022 U.S. Dist. LEXIS 156714 (C.D. Cal. Aug. 30, 2022) (ruling against the FDA in its attempt to stop stem cell treatments at a clinic in California)
- Buckman Co. v. Plaintiffs' Legal Comm., 531 U.S. 341, 351 n.5, 121 S. Ct. 1012, 148 L. Ed. 2d 854 (2001) (Congress rejected in its authorization of the FDA "any intent to directly regulate the practice of medicine.")
(add to this list)
An emerging concept of major questions doctrine might rein in FDA over-regulation in this field.